Furthermore, abnormal translation of the AMPAR GluA2 subunit via changes in GRIA2 expression or alternative splicing has been implicated in the pathophysiology and the neurological phenotype of a wide array of NDDs, including Fragile X syndrome (FXS) and Rett syndrome (RTT)25–27. The gene discussed is GRIA2; the disease is Rett syndrome.